Aadi Bioscience Inc
(NAS:AADI)
$
1.99
0.03 (1.53%)
Market Cap: 48.98 Mil
Enterprise Value: -29.27 Mil
PE Ratio: 0
PB Ratio: 0.62
GF Score: 42/100 Aadi Bioscience Inc at Jefferies London Healthcare Conference Transcript
Nov 14, 2023 / 08:30AM GMT
Release Date Price:
$4.77
(+4.61%)
Roger Song
Jefferies LLC - Analyst
All right. All right. Welcome, everyone, to day one at Jefferies Healthcare Conference in London. So our next presenting company is Aadi Bioscience. Welcome, Dave and Scott.
Scott Giacobello
Aadi Bioscience, Inc. - CFO
Good morning.
Dave Lennon
Aadi Bioscience, Inc. - President & CEO
Thank you, Roger.
Questions & Answers
Roger Song
Jefferies LLC - Analyst
Awesome. Yeah. So maybe we start from overview. If people are new to your Aadi story or know you for a while but haven't really followed for the recent updates, what is your updated elevator pitch for the investors?
Dave Lennon
Aadi Bioscience, Inc. - President & CEO
Yeah, sure. Thanks, Roger. Thanks for allowing us to attend today at Jefferies, and welcome, everyone. Thank you for coming. So we're Aadi Biosciences. I'm the new CEO, Dave Lennon. I joined in the beginning of October and have been delighted to be
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot